Alemtuzumab MabCampath

Learn about your cancer drugs.
This chemotherapy and cancer drugs article is about Alemtuzumab (MabCampath) Chemotherapy a biological therapy generally used to treat chronic lymphocytic leukaemia (CLL).  It is a monoclonal antibody a new type of drug which recognises certain proteins that are found on the surface of some types of cancer cells. Once the monoclonal antibody recognises the protein it attaches itself to it, which is thought to then trigger the body’s immune system to attack the cancer cells and cause the cells to destroy themselves.  MabCampath works on to a protein called CD52. This is found on the surface of certain white blood cells (lymphocytes), including those affected by the leukaemia. It is given intravenously and usually after chemotherapy has failed or if the CCL has returned.

Side effects can include: some initial allergic reaction; later reactions such as lowered resistance to infection, flu-like symptoms, nausea; low blood pressure, diarrhoea, constipation.

Other articles that you may find interesting are:

  1. Diet for Chemotherapy ;

  2. beneficial bacteria ;

  3. A-Z guide to complementary therapies;

  4. Your cancer, where you can read about everything from causes to cancer treatments to complementary therapies for your cancer.

  5. How to boost your immune system.

To return to the drug list, click here.

Learn about your cancer drugs.
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our

Join Our Newsletter Signup today for free and be the first to get notified on new updates.